James Barder, chief executive officer at Futura Medical PLC (LON:FUM) tells Proactive Investors the company has closed the recruitment of patients







Futura Medical hopes erectile dysfunction gel trial will show superiority of treatment [VGNlKZl9ja0]

Futura Medical hopes erectile dysfunction gel trial will show superiority of treatment [VGNlKZl9ja0]

| 1h 28m 28s | Video has closed captioning.

James Barder, chief executive officer at Futura Medical PLC (LON:FUM) tells Proactive Investors the company has closed the recruitment of patients in its clinical study of MED2002, a gel the company has developed for the treatment of erectile dysfunction (ED). Barder expects the study to complete mid-summer, and to confirm that the treatment works faster than standard ED treatments like Viagra and is also safer for patients. #2024 male enhancement award #arthritis gummies for adults

Aired: December 22, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now